Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
6 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Induction of HIV-1-neutralising and syncytium-inhibiting antibodies in uninfected recipients of HIV-1IIIB rgp120 subunit vaccine.
Lancet. 1993 Jul 10;342(8863):69-73. doi: 10.1016/0140-6736(93)91283-r.
Lancet. 1993.
PMID: 8100910
Free article.
Clinical Trial.
Randomised trial of MNrgp120 HIV-1 vaccine in symptomless HIV-1 infection.
Eron JJ Jr, Ashby MA, Giordano MF, Chernow M, Reiter WM, Deeks SG, Lavelle JP, Conant MA, Yangco BG, Pate PG, Torres RA, Mitsuyasu RT, Twaddell T.
Eron JJ Jr, et al. Among authors: twaddell t.
Lancet. 1996 Dec 7;348(9041):1547-51. doi: 10.1016/s0140-6736(96)05283-x.
Lancet. 1996.
PMID: 8950881
Free article.
Clinical Trial.
Item in Clipboard
Phase II study of weekly intravenous recombinant humanized anti-p185HER2 monoclonal antibody in patients with HER2/neu-overexpressing metastatic breast cancer.
Baselga J, Tripathy D, Mendelsohn J, Baughman S, Benz CC, Dantis L, Sklarin NT, Seidman AD, Hudis CA, Moore J, Rosen PP, Twaddell T, Henderson IC, Norton L.
Baselga J, et al. Among authors: twaddell t.
J Clin Oncol. 1996 Mar;14(3):737-44. doi: 10.1200/JCO.1996.14.3.737.
J Clin Oncol. 1996.
PMID: 8622019
Clinical Trial.
Item in Clipboard
Phase II study of receptor-enhanced chemosensitivity using recombinant humanized anti-p185HER2/neu monoclonal antibody plus cisplatin in patients with HER2/neu-overexpressing metastatic breast cancer refractory to chemotherapy treatment.
Pegram MD, Lipton A, Hayes DF, Weber BL, Baselga JM, Tripathy D, Baly D, Baughman SA, Twaddell T, Glaspy JA, Slamon DJ.
Pegram MD, et al. Among authors: twaddell t.
J Clin Oncol. 1998 Aug;16(8):2659-71. doi: 10.1200/JCO.1998.16.8.2659.
J Clin Oncol. 1998.
PMID: 9704716
Clinical Trial.
Item in Clipboard
Phase II study of weekly intravenous trastuzumab (Herceptin) in patients with HER2/neu-overexpressing metastatic breast cancer.
Baselga J, Tripathy D, Mendelsohn J, Baughman S, Benz CC, Dantis L, Sklarin NT, Seidman AD, Hudis CA, Moore J, Rosen PP, Twaddell T, Henderson IC, Norton L.
Baselga J, et al. Among authors: twaddell t.
Semin Oncol. 1999 Aug;26(4 Suppl 12):78-83.
Semin Oncol. 1999.
PMID: 10482197
Clinical Trial.
Item in Clipboard
Phase I assessment of the pharmacokinetics, metabolism, and safety of emitefur in patients with refractory solid tumors.
Nemunaitis J, Eager R, Twaddell T, Corey A, Sekar K, Tkaczuk K, Thompson J, Hoff PM, Pazdur R.
Nemunaitis J, et al. Among authors: twaddell t.
J Clin Oncol. 2000 Oct 1;18(19):3423-34. doi: 10.1200/JCO.2000.18.19.3423.
J Clin Oncol. 2000.
PMID: 11013283
Clinical Trial.
Item in Clipboard
Cite
Cite